Zebra Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Zebra Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-23,400	Closed	-$115K	–	183
2021 Q3	$115K	Hold	23,400	–	–	0.14%	171
2021 Q2	$124K	Hold	23,400	–	–	0.15%	148
2021 Q1	$112K	Buy	+23,400	New	+$122K	0.12%	160

Zebra Capital Management's ADMS Position: Q4 2021 in Review

Zebra Capital Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 23,400 shares — an estimated $115K sold.

Zebra Capital Management first reported a position in ADMS in Q1 2021 and held it in 3 quarters. The position peaked at $124K in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Zebra Capital Management reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Zebra Capital Management sold 23,400 Adamas Pharmaceuticals shares in Q4 2021, an estimated $115K.
Zebra Capital Management first reported a position in Adamas Pharmaceuticals in Q1 2021 and held it in 3 quarters.
Zebra Capital Management's Adamas Pharmaceuticals position peaked at $124K in Q2 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Zebra Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.